Dendritic cell-based immunotherapy

• Preclinical development and clinical safety assessment of a synthetic peptide conjugate enabling endogenous antibody binding to promote innate receptor engagement

  2025 Molecular Therapy Oncology article Immunology and Microbiology Immunotherapy and Immune Responses Open access

  1

  citations
• Lymph node and tumor-associated PD-L1+ macrophages antagonize dendritic cell vaccines by suppressing CD8+ T cells

  2024 Cell Reports Medicine article Medicine Cancer Immunotherapy and Biomarkers Open access

  55

  citations
• Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in vitro and in vivo

  2023 Cellular and Molecular Life Sciences article Immunology and Microbiology Immunotherapy and Immune Responses Open access

  4

  citations
• A lymph node-to-tumour PDL1 + macrophage circuit antagonizes dendritic cell immunotherapy

  2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Immunology and Microbiology Immunotherapy and Immune Responses Open access

  4

  citations
• Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells

  2020 Frontiers in Immunology article Immunology and Microbiology Immunotherapy and Immune Responses Open access cited by 2 patents

  20

  citations
• Nucleic acid nanotechnology for cancer treatment

  2020 Biochimica et Biophysica Acta (BBA) - Reviews on Cancer article Biochemistry, Genetics and Molecular Biology RNA Interference and Gene Delivery

  52

  citations

6 results